Abstract
Chemotherapy is the firsthand choice of any cancer therapy including leukemia. However, immunosuppression is commonly seen in leukemic patients. So for the management of leukemia, cytokine-based immunotherapy is also suggested as either a combination therapy along with the conventional chemotherapy or alone. However, therapy is applied on individual patients on the basis of evidence-based medicine, i.e., population-based statistical analysis and/or on the basis of clinicians’ personal experience. Here, we propose an analytical rationality for therapeutic selection among these two options. Our simulation runs suggest that choice would be based on individual patients’ patho-physiological state like immunity profile or another hematological status. Simulation runs also suggest that in some cases chemotherapy may bring detrimental effect and direct immunotherapy would be beneficial for long-term successful therapeutic outcome. Further, this model helps in the optimization of cytokine-based immunotherapy protocol.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
DeLsi, C., Rescigno, A.: Immnue surveillance and neoplasia 1 a minimal mathematical model. Bulletin of Mathematical Biology. 39 (1977) 201–221.
Grossman, B.G.: Tumour escape from immune elimination J Theor Biol 83 (1980) 267–296.
Kustnetsov, V.A., Malakin, A.M., Taylor, M.A., Perelson, A.S.: Nonlinear dynamics of immunogenic tumors: Parameter estimation and global bifurcation analysis, Bull. Math. Bio. 56 (1994) 295–321.
Preziosi, L.: From population dynamics to modeling the competition between tumors and immune system Mathl. Comput. Modelling. 23 (1996) 135–152.
Michor, F., Beal, K.: Improving cancer treatment via mathematical modeling of population dynamics. Cell. 163 (2015) 1059–1063.
Bellomo, N., Forni, G.: Dynamics of tumor interaction with the host immune system, Mathl. Comput. Modelling 20 (1994) 107–122.
Kolev, M.: Mathematical modeling of the competition between tumors and immune system considering the role of the antibodies. Mathl. Comput. Modelling. 37 (2003) 1143–1152.
Kim, P.S., Lee, P.P., Levy, D.: Dynamics and potential impact of the immune response to chronic myelogenous leukemia, PLoS Comp Biol. 4 (2008):e1000095.
Kim, P.S., Lee, P.P., Levy, D.: A PDE model for imatinib-treated chronic myelogenous leukemia. Bull. Math. Biol. 70 (2008) 1994–2016.
Foo, J., Drummond, M.W., Clarkson, B., Holyoke, T., Michor, F.: Eradication of chronic myeloid leukemia stem cells: a novel mathematical model predicts no therapeutic benefit of adding G-CSF to imatinib. PLoS Computational Biology. 5 (2009), e10000503.
Dhar, P.K., Mukherjee, A., Majumder, D.: Difference delay equation-based analytical model of hematopoiesis. Aut. Contrl. Physiol. State. Func. 1 (2012) 1–11.
Dhar, P.K., Majumder, D.: Development of the analytical model for the assessment of the efficiencies of different therapeutic modalities in leukaemia. J. Comp. Syst. Biol. 1 (2015) 1–45.
Michor, F., Hughes, T.P., Iwasa, Y., Branford, S., Shah, N.P., Sawyers, C.L., Nowak, M.A.: Dynamics of chronic myeloid leukemia. Nature 435 (2005) 1267–1270.
Acknowledgements
PKD is pursuing Ph.D. from Jadavpur University. All authors acknowledge the logistic support provided by Society for Systems Biology & Translational Research.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this paper
Cite this paper
Dhar, P.K., Naskar, T.K., Majumder, D. (2018). Optimal Choice Between Chemotherapy and Immunotherapy for Leukemia Treatment Depends on Individual Patients’ Patho-physiological State. In: Pattnaik, P., Rautaray, S., Das, H., Nayak, J. (eds) Progress in Computing, Analytics and Networking. Advances in Intelligent Systems and Computing, vol 710. Springer, Singapore. https://doi.org/10.1007/978-981-10-7871-2_62
Download citation
DOI: https://doi.org/10.1007/978-981-10-7871-2_62
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-7870-5
Online ISBN: 978-981-10-7871-2
eBook Packages: EngineeringEngineering (R0)